Quercetin Synergistically Enhances the Anticancer Efficacy of Docetaxel through Induction of Apoptosis and Modulation of PI3K/AKT, MAPK/ERK, and JAK/STAT3 Signaling Pathways in MDA-MB-231 Breast Cancer Cell Line

Docetaxel is widely used in the treatment of metastatic breast cancer. However, its effectiveness is limited due to chemoresistance and its undesirable side effects. The combination of chemotherapeutic agents and natural compounds is an effective strategy to overcome drug resistance and the ensuing...

Descripción completa

Detalles Bibliográficos
Autores principales: Safi, Amir, Heidarian, Esfandiar, Ahmadi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256834/
https://www.ncbi.nlm.nih.gov/pubmed/34268250
http://dx.doi.org/10.22088/IJMCM.BUMS.10.1.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256834/
https://www.ncbi.nlm.nih.gov/pubmed/34268250
http://dx.doi.org/10.22088/IJMCM.BUMS.10.1.11

Ejemplares similares